summari morn report result
maintain outlook quarterli print came ahead
consensu estim beat larg expect
investor focus magnitud beat go
quarter given zbh recent progress suppli product
approv well manag bullish commentari around
aao american academi orthoped surgeon mid-march
deliv ex-fx organ sale growth day-adjust basi
y/i compar day-adjust growth
investor focu stack two-
year growth appear deceler
sequenti basi like part due season believ
zbh turnaround underway like begin see
organ revenu growth ramp get offenc
begin result estim rel
unchang revenu estim
y/i organ ep unchang y/i
expect deliv ex-fx day adjust growth in-lin
level organ improv organ exit
year market growth rate
deliv beat driven emea recon hip
knee report revenu y/i
y/i ex-fx came estim
consensu ep y/i
penni better consensu forecast
revenu ep guidanc rang provid
three factor anticip play quarter
fx headwind one less sell day
headwind bone cement suppli issu
headwind adjust fx sell day impact
report organ sale growth y/i came
ahead estim geographi beat rel
estim driven europ middl east africa emea
beat driven hip follow asiapacif beat
america came slightli miss segment
beat rel estim driven hip beat knee
beat beat off-set set sport
medicin extrem trauma
craniomaxiollofaci dental miss larg in-lin
overal better-than-expect top-lin growth drove ep beat
even oper margin om estim
continu page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort non-recur item
compani data secur llc estim reuter
continu previou page
see major chang outlook continu make progress toward goal
achiev growth left outlook intact compani look deliv organ
top-lin growth includ fx headwind rang manag
continu expect growth fx headwind eas sell day impact revers
headwind tailwind net neutral full year get offenc full bag new
product call manag note sell day impact roughli equal weight
estim respect impact revers
major benefit estim quarterli cadenc manag note
continu lose share get offenc note growth
come in-lin growth would impli sequenti acceler two-year stack growth
math look expect gross margin slightli higher y/i full year due fx
hedg gain versu prior outlook margin expans continu expect om rang
y/i driven business-rel invest posit compani
long-term growth posit offenc model om lower-end
rang higher level volum ramp chang tax rate
expect continu rang flat y/i net-net ep outlook
maintain y/i versu unchang estim compani plan
gener free cash flow note debt repay remain first use cash
zbh net leverag ratio around manag note comfort look target even
though laser focus deliv turnaround point
segment result stack follow zbh result rel estim driven
recon hip knee set spine cmf dental track in-lin expect
sale growth repres y/i ex-fx rate adjust impact sell day
impact growth respect segment zbh result stack
knee sale better estim knee sale versu
compar estim result driven sequenti
acceler america off-set deceler europ middl east africa emea
deceler asiapacif varianc rel estim came intern market
america spot overal knee price slightli wors sequenti versu
due one-tim price benefit price environ appear stabl knee y/i
declin volum sequenti versu like result
season expect drive growth full portfolio knee product persona
famili knee rosa tka total knee arthroplasti applic begin full launch
model growth versu rosa launch particular focu
manag highlight key featur call includ ct pre-op plan less
radiat exposur major disrupt surgic flow accuraci due dynam track featur
manag note enough suppli meet initi demand placement strategi
first focu platinum account highest volum account follow
gold account share along competitor follow new account key
goal drive procedur growth thu make financ option avail custom
need manag expect drive growth knee driven first mix shift robot cementless
revis competit account convers
hip sale better estim hip sale versu
compar estim sequenti acceler driven
acceler asiapacif somewhat off-set deceler america
emea varianc rel estim driven emea manag provid
much color call appear overal hip growth well within market growth rang
hip price wors sequenti versu volum improv
versu thu far appear global hip market acceler
growth driven intern market us market declin
set sale spot estim sport medicin extrem trauma set sale
versu compar estim set remain
attract market even though price versu volum versu
trend deceler like due season manag note call set
area focu within set upper extrem shoulder especi stemless area focu
launch sidu stemless shoulder last year gain much traction bode well
wmgi simplic appear execut continu challeng even though made
leadership chang last year extrem area expect doubl
continu monitor compani set strategi go forward
spine cmf sale in-lin estim spine craniomaxillofaci cmf sale
versu compar estim spine cmf
price versu volum versu
sequenti deceler like due continu impact sale forc integr dis-
synergi spine off-set benefit uptak cmf thorac product manag note
call expect activ portfolio manag spine side given
attract bucket growth name minim invas surgeri robot cervic disc specif
ceo brian hanson note focu stabil core busi move aggress
busi develop area strateg relev offer good return
dental sale also in-lin estim dental sale versu
compar estim dental price improv versu
along volum versu result sequenti improv
manag highlight progress dental busi call work new
market strategi within dental busi appear make progress driven portfolio
realign sale reorgan certain geographi alloc greater resourc
dental busi give chanc turnaround initi look get traction
price target nc
price target base approxim cash ep estim risk thesi
includ increas invest slower procedur volum growth price pressur disrupt
integr biomet
zimmer biomet share trade roughli discount large-cap med-tech peer group believ
discount narrow compani benefit leadership new commercially-driven
ceo bryan hanson oper issu resolv pipelin begin fulli
warsaw indiana-bas zimmer biomet hold one world largest orthoped implant
manufactur compani global market leader billion reconstruct orthoped
implant busi hip knee implant togeth account roughli revenu
compani report sale billion
